|
Forecast Period
|
2024-2028
|
|
Market Size (2022)
|
USD 30.46 Billion
|
|
CAGR (2023-2028)
|
6.11%
|
|
Fastest Growing Segment
|
Combination Pills
|
|
Largest Market
|
North America
|
Market Overview
Global Contraceptive Pills Market has
valued at USD 30.46 Billion in 2022 and is anticipated to project impressive
growth in the forecast period with a CAGR of 6.11% through 2028. Contraceptive pills,
also known as birth control medications, are specifically designed to prevent
pregnancy and regulate birth rates. These medications are synthetically
formulated using a combination of two female hormones, estrogen and progestin.
By effectively inhibiting ovulation, these hormones play a crucial role in
preventing the release of eggs from the ovaries. Contraceptive pills not only
prevent ovulation but also thicken the cervical mucus, making it more difficult
for sperm to reach the egg for fertilization. Additionally, they can alter the
lining of the womb, creating an environment that is unfavorable for the
implantation of a fertilized egg. By targeting these key mechanisms,
contraceptive pills provide a highly effective means of birth control. In
addition to their primary purpose of preventing unwanted pregnancies,
contraceptive pills offer several other benefits. They have been found to
reduce the risks of acne, bone thinning, and certain types of cancers, such as
ovarian cancer. Moreover, they can help prevent infections in the fallopian
tubes and uterus, as well as alleviate symptoms of premenstrual syndrome (PMS).
Given their significant impact on
women's reproductive health, contraceptive pills are typically prescribed and
administered by healthcare practitioners. These medications are available in
various forms, including oral pills, injectables, and topical formulations,
providing women with a range of options to choose from based on their individual
needs and preferences. With ongoing advancements in medical research and
technology, the field of contraceptive pills continues to evolve, offering
women more choices and improved effectiveness in preventing unplanned
pregnancies.
Key Market Drivers
Increase
in Population Control Program
The efforts made by governments to
reduce population growth in various nations are not only raising women's
understanding of family planning and contraception, but also bringing about
significant changes in both urban and rural settings. In industrialized
markets, the use of oral contraceptives has witnessed a substantial increase
due to the rising occurrence of unintended pregnancies, prompting individuals
to take proactive measures for contraception. As the population continues to
expand at a rapid rate, particularly in Asian countries, the micro-level impact
on the socio-economic balance becomes more evident. Recognizing the urgency of
the situation, public and private players are joining hands to effectively
manage the population growth, with a vision of bringing about a positive
transformation in sex education and contraception use in the years to come. It
is anticipated that these collaborative efforts will not only drive the market
CAGR for contraceptive pills but also result in an overall improvement in
healthcare outcomes. Thus, the revenue from the contraceptive pills market is
predicted to experience a steady increase throughout the forecast period,
reflecting the growing importance of addressing population growth and advancing
reproductive health worldwide.
Increasing
Availability of Free and Subsidized Contraceptive Drugs
As governments around the world strive
to improve the quality of life for their citizens, they are increasingly taking
steps to promote access to free and subsidized contraceptive drugs. These
efforts have not only resulted in the growth of the contraceptive market, but
also in the overall well-being of individuals and communities.
In particular, low- and middle-income
countries have launched various initiatives to raise awareness and promote the
use of contraceptive drugs among their populations. For example, the Health
Ministry of India released a series of commercials in July 2019 to promote oral
contraceptives, highlighting their benefits and importance. Additionally,
governments have made contraceptive pills available at pharmacy stores without
the need for doctor's prescriptions, making them more accessible to individuals
who may otherwise face barriers to obtaining them.
Furthermore, the implementation of
family planning programs and media campaigns has played a crucial role in
increasing awareness about the benefits of contraceptive drugs. These
initiatives have not only educated individuals about the various contraceptive
options available, but also helped remove the stigma surrounding their use.
Moreover, efforts have been made to ensure that contraceptive services are
accessible to underserved populations, including through the redistribution of
services among health workers and pharmacy staff. This has led to increased
availability of injectables and oral contraceptives for those who previously
had limited access.
In addition to these advancements, the
market for contraceptive drugs continues to benefit from the development of new
technologies aimed at enhancing their functionality and efficiency. These
innovative approaches not only improve the effectiveness of contraceptive
methods, but also provide individuals with more options to choose from.
Overall, the increasing availability and
promotion of diverse contraceptive drugs in developing countries, coupled with
the development of new technologies, are driving the growth of the
contraceptive market. These efforts not only empower individuals to make
informed choices about their reproductive health, but also contribute to the
overall well-being and progress of societies.
Increasing
Incidence of the STDs
The increasing incidence of sexually
transmitted diseases (STDs) has brought about a significant surge in the demand
for contraceptive pills, reflecting a complex interplay between public health
concerns and individual reproductive choices. This rise in demand can be
attributed to several interrelated factors. The heightened awareness of the
risks associated with STDs has prompted more individuals to take precautions to
protect themselves. Condoms have traditionally been a primary means of
protection against both unwanted pregnancies and STD transmission, but they may
not always be consistently and correctly used. As a result, many people are
turning to contraceptive pills as an additional layer of protection. These
pills, when taken consistently and as prescribed, can help prevent unintended
pregnancies, offering peace of mind to those engaging in sexual activity,
especially with new or multiple partners.
Furthermore, the stigma surrounding STDs
and the potential long-term health consequences have spurred individuals to
seek methods that provide both pregnancy prevention and STD protection.
Contraceptive pills, while primarily designed to prevent pregnancy, are
increasingly being recognized for their role in reducing the risk of
contracting certain STDs, such as pelvic inflammatory disease (PID). This dual
benefit is driving more individuals to consider and request contraceptive pills
from healthcare providers. The increasing incidence of STDs has
fueled the demand for contraceptive pills, as individuals seek comprehensive
protection against both unwanted pregnancies and the transmission of sexually
transmitted infections. This trend reflects a growing awareness of sexual
health risks and a desire to take proactive measures to safeguard one's
well-being. As society continues to prioritize sexual health education and
access to contraceptives, the demand for contraceptive pills is likely to
remain on an upward trajectory.
Rise
In Awareness of Modern Contraceptive Medications In Developing Countries
The rise in awareness of modern
contraceptive medications in developing countries has significantly increased
the demand for contraceptive pills, marking a crucial turning point in
reproductive healthcare. Several key factors contribute to this growing demand
and its far-reaching implications. Heightened awareness campaigns and
educational initiatives have played a pivotal role in informing individuals,
particularly women, about the diverse range of contraceptive options available.
This includes raising awareness about the efficacy, safety, and convenience of
contraceptive pills. As more people become educated about these options, they
are better equipped to make informed choices about their reproductive health.
This knowledge empowers women to exercise greater control over their family
planning, contributing to smaller, well-timed families and improved maternal
and child health.
Additionally, the changing societal
landscape and evolving gender dynamics in many developing countries are
encouraging discussions about family planning. As women's rights and gender
equality gain momentum, contraceptive pills are seen as a means for women to
take control of their reproductive health, pursue educational and career
opportunities, and make choices aligned with their life goals. This changing
perspective is driving an increased demand for contraceptive pills among women
who aspire to balance their family planning decisions with their personal and
professional aspirations.
The expansion of healthcare
infrastructure in many developing countries has facilitated greater access to
contraceptive services, including contraceptive pills. Outreach programs,
community health workers, and government initiatives have made these medications
more readily available, especially in rural and underserved areas. This
accessibility has contributed to a rise in demand, as women and couples are now
able to access modern contraceptive methods with greater ease.
Download Free Sample Report
Key Market Challenges
High
Cost of Devices and Treatment
The high cost of devices and treatment
options is having a notable impact on the demand for contraceptive pills,
creating financial barriers that hinder access for many individuals and
couples. This trend reflects a complex interplay of economic factors that are shaping
choices in reproductive healthcare. One of the primary reasons for the
decreasing demand for contraceptive pills is the substantial upfront cost
associated with alternative contraceptive methods. Devices such as intrauterine
devices (IUDs) or contraceptive implants, while highly effective, often require
a significant initial investment for insertion or implantation. This cost can
be prohibitive for individuals without adequate insurance coverage or financial
resources, causing them to opt for less expensive alternatives, including
contraceptive pills.
Furthermore, ongoing maintenance and
follow-up costs for certain contraceptive devices can add to the financial
burden. For example, IUDs may require periodic check-ups or replacements,
incurring additional expenses over time. In contrast, contraceptive pills have
the advantage of a more predictable and manageable monthly cost, making them a
more financially accessible option for many.
In addition to device costs, the expense
of medical consultations and treatments associated with certain contraceptive
methods can dissuade individuals from pursuing those options. Procedures like
sterilization or permanent contraception can be costly and may not be covered
by insurance, making them inaccessible for those with limited financial means.
As a result, contraceptive pills, which are available with a prescription but
typically require fewer medical interventions, remain a more affordable choice
for many.
However, it's important to note that the
declining demand for contraceptive pills due to high device and treatment costs
is not uniform across all populations. In some cases, individuals and couples
who can afford the upfront costs of more effective devices may choose them over
contraceptive pills, leading to variations in contraceptive choices based on
economic status. The high cost of contraceptive devices and associated
treatments is indeed reducing the demand for contraceptive pills, particularly
among individuals and couples with limited financial resources. While
contraceptive pills offer an affordable and accessible option, addressing the
financial barriers to alternative methods is crucial to ensuring equitable
access to a wide range of contraceptive choices for all individuals, regardless
of their economic circumstances.
Side
Effects Associated with the Use of Contraceptive Drugs and Devices
The demand for contraceptive pills has
been impacted by the side effects associated with their use, leading to a
decrease in their popularity among some individuals and contributing to a
shifting landscape in reproductive healthcare choices. These side effects,
while not experienced by everyone, are a significant consideration for many.
One of the most commonly reported side
effects of contraceptive pills is hormonal fluctuations, which can lead to a
range of physical and emotional symptoms. These may include mood swings, breast
tenderness, weight gain, and changes in menstrual patterns. For some
individuals, these side effects can be uncomfortable or disruptive to their
daily lives, leading them to seek alternative contraceptive methods that do not
involve hormonal intervention. Concerns about potential long-term health risks
associated with hormonal contraceptives have prompted some individuals to
explore non-hormonal options. These concerns may include an increased risk of
blood clots, cardiovascular issues, or an impact on bone density. As a result,
those who are particularly health-conscious or have underlying medical
conditions may opt for non-hormonal contraceptive devices or methods to
mitigate these potential risks.
The convenience and effectiveness of
long-acting reversible contraceptives (LARCs) such as intrauterine devices
(IUDs) and contraceptive implants have also contributed to the decline in
demand for contraceptive pills. LARCs require less user compliance and offer
highly effective, low-maintenance contraception with fewer hormonal side
effects. This has made them an appealing choice for many individuals seeking a
hassle-free and dependable contraceptive option. The side effects associated
with the use of contraceptive pills have led to a decrease in their demand as
individuals seek alternatives that align better with their preferences and
concerns. While contraceptive pills remain a widely used method, the landscape
of contraceptive choices is evolving to include a broader range of options to
cater to diverse needs and preferences, including those individuals who are
concerned about the potential side effects of hormonal contraception.
Key Market Trends
Non-Hormonal
Alternative
Growing concerns about hormonal side
effects may lead to increased demand for non-hormonal contraceptive pills.
Innovations in this area might include non-hormonal oral contraceptives or
alternative delivery methods. Growing concerns about hormonal side effects
associated with traditional contraceptive pills are indeed driving an increased
demand for non-hormonal contraceptive options. This trend reflects a growing
desire among individuals to have contraceptive choices that minimize hormonal
interventions and their potential side effects. Research and development
efforts are focused on creating non-hormonal oral contraceptive pills that are
effective at preventing pregnancy without altering hormonal balances. These may
include pills containing novel active ingredients that target fertility
mechanisms without affecting hormones.
Advancements in drug delivery technology
may lead to alternative methods of delivering non-hormonal contraceptives, such
as patches, gels, or vaginal rings. Innovations in emergency contraception may
offer non-hormonal alternatives for preventing pregnancy after unprotected
intercourse, providing more options to those who wish to avoid hormonal
interventions.
Personalized
Contraceptive Pills
Advancements in genomics and
personalized medicine could lead to the development of contraceptive pills
tailored to an individual's unique hormonal and genetic profile. This could
enhance effectiveness while minimizing side effects. Advancements in genomics
and personalized medicine hold great promise for the development of
contraceptive pills that can be tailored to an individual's unique hormonal and
genetic profile. This personalized approach to contraception has the potential
to significantly enhance effectiveness while minimizing side effects.
Through genomic testing and analysis,
individuals could have their genetic variations related to hormonal metabolism
and contraceptive response identified. These genetic profiles would provide
insights into how their bodies metabolize hormones and their likely response to
specific contraceptives. Based on an individual's genetic profile, healthcare
providers could prescribe contraceptive pills with formulations that are
optimized for that person's unique physiology. This might involve adjusting the
type and dosage of hormones in the pill to match the individual's specific
needs and minimize potential side effects. Personalized contraceptive pills
could offer a higher level of effectiveness because they are tailored to the
individual's genetic makeup. This customization would increase the likelihood
of successful contraception while reducing the risk of unintended pregnancies.
Advancements in genomics and personalized medicine have the potential to
revolutionize contraception by tailoring contraceptive pills to individuals'
unique hormonal and genetic profiles. This approach could enhance effectiveness
and minimize side effects, offering a more tailored and effective solution for
family planning and reproductive health.
Segmental Insights
Sales Channel Insights
Based on the sales channel, the market is segmented into hospital
pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment
accounted for the largest revenue share in 2022, driven by the growing demand
for contraceptive pills among the public. With increased awareness of various
contraceptive drug options, more people are opting for birth control tablets.
These tablets are readily available over the counter in many nations, making
retail pharmacies the go-to destination for customers seeking them.
Moreover,
favourable regulations have played a significant role in the expansion of the
retail pharmacy segment, creating a conducive environment for growth. The ease
of access and convenience provided by retail pharmacies have further solidified
their position as the preferred choice for obtaining birth control tablets. The
online distribution channel segment is projected to experience the fastest
growth rate during the forecast period. This can be attributed to the rising
popularity of over-the-counter solutions, coupled with the availability of
numerous online discounts and offers that entice clients. The convenience of
ordering contraceptives online, along with the added advantage of attractive
deals, has contributed to the substantial growth of online channels.
The combination of increasing demand for contraceptive pills and
the convenience offered by both retail pharmacies and online channels is
shaping the landscape of the contraceptive market.
Category Insights
Based on
the category segment, the market is segmented into generic & branded. Generic
contraceptive pills have gained dominance over branded counterparts for several
compelling reasons, shaping the landscape of reproductive healthcare choices. One
of the most prominent reasons for the prevalence of generic contraceptive pills
is their cost-effectiveness. Generic medications are typically more affordable
than their branded counterparts. This affordability makes them accessible to a
broader range of individuals, including those with limited financial resources,
thereby promoting equitable access to contraception.
Generic contraceptive
pills contain the same active ingredients and are required to meet the same
safety and efficacy standards as their branded counterparts. Regulatory
agencies rigorously evaluate and approve generic medications to ensure they are
therapeutically equivalent, providing users with confidence in their
effectiveness. The presence of multiple manufacturers producing generic
contraceptive pills fosters healthy competition, which drives down prices. This
competition incentivizes innovation and leads to a wide variety of generic
options, enabling individuals to choose the most suitable product for their
needs. Patients often express a preference for generic medications due to their
affordability and equivalent therapeutic benefits. This preference can
influence healthcare providers' prescription practices, further promoting the
use of generic contraceptive pills.
Download Free Sample Report
Regional Insights
North
America is projected to dominate the global contraceptives market, accounting
for the largest share among all regions. This is attributed to the rising
prevalence of sexually transmitted diseases, which in turn drives the demand
for contraceptives as a preventive measure against sexually transmitted
infections. Consequently, the overall growth of the contraceptives market is
expected to witness a significant boost.
Moreover,
the increasing incidence of unwanted pregnancies further underscores the need
for effective contraception methods, thereby fueling the growth of the contraceptives
market. Additionally, the United States experiences high abortion rates,
leading to a surge in demand for oral contraceptives. As a result, the growth
of the contraceptives market is anticipated to register a considerable upswing.
These
trends highlight the crucial role that North America plays in shaping the
global contraceptives market, as the region not only addresses the rising
concerns of sexually transmitted diseases but also caters to the growing need
for contraception and family planning.
Recent Developments
- July 2022: HRA
Pharma, a pharmaceutical company based in Paris, has announced its intention to
seek FDA clearance for an over-the-counter birth control pill. This particular
pill, known as a mini pill, contains only progestin and no estrogen. If
approved, it would become the first oral contraceptive available without a
prescription in the United States.
- February 2022:
Mithra and Searchlight Pharma have jointly launched Myring, a vaginal
contraceptive ring developed by Mithra, under the brand name Haloette in
Canada.
- January 2020: Theramex, a specialty pharmaceutical company focused on
women's health, has acquired the rights to Zoely®, a patented oral
contraceptive developed by Merck & Co. The financial details of this
acquisition remain undisclosed. This strategic move enables Theramex to expand
its global presence and enrich its portfolio with innovative treatment options
for women.
Key Market Players
- Bayer AG
- Amneal Pharmaceuticals LLC
- Teva Pharmaceuticals Industries Ltd.
- Abbvie Inc. (Allergan PLC)
- Pfizer Inc.
- Johnson & Johnson
- Aurobindo Pharma Limited
- Organon International (Merck & Co. Inc.)
- Sanofi SA
- Mayne Pharma Group Ltd
|
By Pill Type
|
By Category
|
By Sales Channel
|
By Region
|
|
Progestin Pills
Combination Pills
|
Generic
Branded
|
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
|
North America
Europe
Asia Pacific
South America
Middle East &
Africa
|
|
|
|
|
|
Report Scope:
In this report, the Global Contraceptive Pills Market
has been segmented
into the following categories, in addition to the industry trends which have
also been detailed below:
·
Contraceptive Pills Market, By Pill Type:
o
Progestin Pills
o
Combination Pills
·
Contraceptive Pills Market, By Category:
o
Generic
o
Branded
·
Contraceptive Pills Market, By Sales Channel:
o
Hospital Pharmacy
o
Retail Pharmacy
o
Online Pharmacy
·
Contraceptive Pills Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Global Contraceptive Pills Market.
Available Customizations:
Global Contraceptive Pills market report with the given market data,
TechSci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
Global Contraceptive Pills Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]